The Hidden Gaps in Mosquito Genomics That Could Undermine Dengue Control

In the Indo-Pacific, where dengue infects over 390 million people annually, just 3% of publicly available Aedes aegypti whole genomes come from the region. That mismatch — between disease burden and genomic representation — is not a minor oversight. It is a critical blind spot in global efforts to control one of the world’s fastest-growing vector-borne diseases (Jasper et al., 2026).

This imbalance is one of several systemic biases uncovered in a sweeping new review of the molecular genetics of Aedes aegypti, the mosquito responsible for transmitting dengue, Zika, chikungunya, and yellow fever. The paper, by Moshe E. Jasper, Thomas L. Schmidt, and Ary A. Hoffmann, reveals how decades of technological constraints, research priorities, and genomic complexity have shaped — and in some cases distorted — our understanding of this deadly insect. While Ae. aegypti has finally entered the whole-genome era, with hundreds of individual genomes now sequenced and accessible, the legacy of earlier methods continues to influence what scientists see, what they miss, and where they look next.

The implications are urgent. As climate change expands the mosquito’s range and urbanization fuels its spread, the need for precise, genetically informed control strategies has never been greater. Yet the very tools meant to guide those strategies — genomic data — are skewed toward regions with lower transmission and away from the epicenters of disease.

The Science

Aedes aegypti is not just any mosquito. It is a human-adapted, day-biting, container-breeding specialist that thrives in cities across the tropics and subtropics. Unlike its rural, night-biting cousin Anopheles gambiae — the primary malaria vector — Ae. aegypti evolved alongside humans, feeding almost exclusively on us and breeding in discarded tires, flower pots, and water storage containers. This close association makes it a uniquely efficient disease vector.

For decades, researchers have studied its genetics to understand how it spreads, adapts, and resists insecticides. Early work relied on molecular markers like microsatellites and allozymes, which offered coarse-grained views of population structure. Later, candidate gene approaches targeted specific loci thought to be involved in insecticide resistance, such as voltage-gated sodium channels (the target of pyrethroids) and acetylcholinesterase (targeted by organophosphates).

But these methods had limits. Microsatellites could reveal broad patterns of migration but not fine-scale adaptation. Candidate gene studies risked missing novel resistance mechanisms. And all were constrained by the lack of a high-quality reference genome.

That changed in 2018, when the first chromosome-level assembly of Ae. aegypti (AaegL5) was released. Since then, dozens of additional genomes have been sequenced from populations around the world, enabling population genomics at an unprecedented scale. Projects like the Mosquito Genomes Project and the Global Vector Hub now host hundreds of Ae. aegypti genomes, opening the door to genome-wide association studies (GWAS), selection scans, and detailed reconstructions of demographic history.

Yet as Jasper and colleagues show, the transition to whole-genome sequencing has not erased the biases of the past. Instead, it has layered new data atop old assumptions, sometimes reinforcing them.

What They Found

The most striking disparity lies in geographic representation. Despite bearing the highest dengue burden globally, the Indo-Pacific region — encompassing Southeast Asia, the Pacific Islands, and northern Australia — is drastically underrepresented in genomic databases. According to the review, only about 3% of published whole-genome sequences of Ae. aegypti originate from this region.

Geographic Distribution of Aedes aegypti Whole Genome Sequences

Label	Value
Americas	62
Africa	25
Indo-Pacific	3
Other	10

Source: Jasper et al. (2026), based on analysis of public genomic databases.

This is not just a data gap; it is a functional one. Populations in the Indo-Pacific have been exposed to decades of insecticide use and intense selection pressure from disease control programs. They are likely to harbor unique genetic variants related to insecticide resistance, host preference, and vector competence. Yet these variants remain largely invisible to researchers relying on existing genomic resources.

"The genetic architecture of resistance in Southeast Asia may be fundamentally different from what we’ve documented in the Americas or Africa," the authors write. "But without representative sampling, we’re effectively flying blind."

A second major finding concerns the role of copy number variation (CNV) in insecticide resistance. For years, research focused on single nucleotide polymorphisms (SNPs) — point mutations that alter protein function. The most famous example is the kdr (knockdown resistance) mutation in the Vgsc gene, which reduces pyrethroid binding and is now widespread in Ae. aegypti populations.

But CNVs — duplications or deletions of large DNA segments — have been largely overlooked, not because they’re unimportant, but because they’re hard to detect. The Ae. aegypti genome is riddled with repetitive sequences and gene families that resist accurate alignment during short-read sequencing. One of the most problematic regions involves the glutathione S-transferase epsilon (GSTe) class of genes, which are known to detoxify insecticides.

Focus of Functional Genetic Studies on Aedes aegypti

Label	Value
Insecticide Resistance	72
Host Preference	8
Vector Competence	7
Biting Behavior	5
Other	8

72 Insecticide Resistance

Estimate based on literature review in Jasper et al. (2026).

The authors cite evidence that GSTe genes are frequently amplified in resistant populations — meaning multiple copies exist per genome — yet standard SNP-calling pipelines often fail to capture these duplications. As a result, studies may attribute resistance to SNPs when the real driver is increased gene dosage.

"We’re missing a key piece of the resistance puzzle because our tools aren’t designed to see it," the researchers argue. "This isn’t just a technical limitation — it’s a conceptual blind spot."

A third insight involves the historical focus on insecticide resistance at the expense of other traits. Because vector control has long relied on chemical sprays, much of the molecular genetics work on Ae. aegypti has centered on resistance mechanisms. But other traits — such as host preference (anthropophily), biting time, and vector competence (the ability to transmit pathogens) — are equally important for transmission dynamics.

Yet these traits are harder to link to specific genes, and until recently, lacked the genomic infrastructure needed for large-scale study. As a result, the literature is skewed: over 70% of functional genetic studies on Ae. aegypti focus on resistance, while fewer than 10% address host-seeking behavior or viral susceptibility (Jasper et al., 2026).

Why This Changes Things

These findings matter because they challenge the assumption that more data automatically leads to better science. In the case of Ae. aegypti, the explosion of genomic data has not been evenly distributed — either geographically or functionally. The result is a distorted map of genetic variation, one that risks misguiding public health interventions.

Consider the rollout of genetically modified mosquitoes. Programs like Oxitec’s OX5034 strain release male mosquitoes carrying a self-limiting gene that kills female offspring. These programs rely on detailed knowledge of local population structure to ensure the modified genes spread effectively. But if the reference genomes used to design these interventions come mostly from Brazil or the Caribbean, how well will they perform in Jakarta or Manila?

"Gene drive systems and other genetic control tools assume a certain level of genetic similarity between lab strains and wild populations," the authors note. "If we’re basing those assumptions on incomplete or biased data, we risk reduced efficacy — or worse, unintended evolutionary consequences."

The same applies to insecticide resistance monitoring. Public health agencies routinely screen mosquito populations for kdr mutations to guide spray campaigns. But if CNVs in GSTe or other detoxification genes are the dominant resistance mechanism in certain regions, then SNP-based diagnostics will give a false sense of security.

This isn’t hypothetical. In a 2023 study in Vietnam, researchers found high levels of pyrethroid resistance despite low kdr allele frequencies — a mismatch that pointed to alternative mechanisms, possibly involving gene amplification (Tran et al., 2023). Without tools capable of detecting CNVs, such cases remain enigmatic.

The geographic bias also has equity implications. The Indo-Pacific bears the brunt of dengue’s burden, yet its mosquitoes are the least studied at the genomic level. This reflects a broader pattern in global health research, where data generation is concentrated in wealthier nations, while disease burden falls disproportionately on low- and middle-income countries.

"It’s a form of scientific colonialism," one researcher familiar with the work commented, asking not to be named. "We’re solving problems in places where the data is easiest to collect, not where the need is greatest."

What’s Next

The authors call for a coordinated effort to rebalance the genomic landscape of Ae. aegypti research. This includes targeted sequencing initiatives in the Indo-Pacific, improved bioinformatics tools for detecting CNVs, and a broader expansion of functional genomics beyond insecticide resistance.

One promising path is long-read sequencing technologies, such as PacBio and Oxford Nanopore, which can span repetitive regions and resolve complex structural variants. These methods are already being used to generate more complete assemblies of Ae. aegypti genomes, including from understudied regions.

"We’re on the cusp of a new era," said Hoffmann in an interview. "But we have to make sure it’s inclusive — not just technologically advanced."

Another priority is the development of standardized CNV-calling pipelines for mosquito genomics. While tools exist for human and model organism genomes, few are optimized for the repetitive, dynamic nature of Ae. aegypti’s DNA. Creating such resources would allow researchers to systematically compare gene copy numbers across populations, potentially uncovering new resistance markers.

There is also growing interest in linking genomic data to phenotypic traits through controlled infection experiments and behavioral assays. For example, recent work has begun to map quantitative trait loci (QTL) associated with dengue virus susceptibility in Ae. aegypti, offering a path toward breeding or engineering mosquitoes with reduced vector competence (Dickson et al., 2024).

But these advances require more than technology. They require a shift in research culture — one that values representativeness as much as innovation, and that treats genomic equity as a public health imperative.

The stakes are high. Dengue cases have increased eightfold over the past two decades, with half the world’s population now at risk. Climate change is pushing Ae. aegypti into new territories, including southern Europe and the southern United States. And with no widely available vaccine or antiviral treatment, vector control remains the primary defense.

Genomics holds immense promise for making that control smarter, more precise, and more sustainable. But only if the data reflects the full diversity of the mosquito — and the people it bites.

As the authors conclude: "The genome is not just a blueprint. It is a historical record, shaped by evolution, ecology, and human action. To read it fully, we must look not only at the sequences we have, but at the ones we’re missing."